139 related articles for article (PubMed ID: 33902275)
1. Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors.
Wang S; Zhu X; Zhangsun M; Wu Y; Yu J; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2021 May; 64(9):5620-5631. PubMed ID: 33902275
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent α-Conotoxin [Q1G, ΔR14]LvIB Identifies the Distribution of
Shan H; Wang N; Gao X; Wang Z; Yu J; Zhangsun D; Zhu X; Luo S
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786593
[No Abstract] [Full Text] [Related]
3. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists.
Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S
Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921
[TBL] [Abstract][Full Text] [Related]
4. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
5. Effects of C-Terminal Carboxylation on α-Conotoxin LsIA Interactions with Human α7 Nicotinic Acetylcholine Receptor: Molecular Simulation Studies.
Wen J; Hung A
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30987002
[TBL] [Abstract][Full Text] [Related]
6. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
7. Interaction of alpha-conotoxin ImII and its analogs with nicotinic receptors and acetylcholine-binding proteins: additional binding sites on Torpedo receptor.
Kasheverov IE; Zhmak MN; Fish A; Rucktooa P; Khruschov AY; Osipov AV; Ziganshin RH; D'hoedt D; Bertrand D; Sixma TK; Smit AB; Tsetlin VI
J Neurochem; 2009 Nov; 111(4):934-44. PubMed ID: 19712060
[TBL] [Abstract][Full Text] [Related]
8. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors.
Talley TT; Olivera BM; Han KH; Christensen SB; Dowell C; Tsigelny I; Ho KY; Taylor P; McIntosh JM
J Biol Chem; 2006 Aug; 281(34):24678-86. PubMed ID: 16803900
[TBL] [Abstract][Full Text] [Related]
9. Structure-function elucidation of a new α-conotoxin, Lo1a, from Conus longurionis.
Lebbe EK; Peigneur S; Maiti M; Devi P; Ravichandran S; Lescrinier E; Ulens C; Waelkens E; D'Souza L; Herdewijn P; Tytgat J
J Biol Chem; 2014 Apr; 289(14):9573-83. PubMed ID: 24567324
[TBL] [Abstract][Full Text] [Related]
10. α-Conotoxin as Potential to α7-nAChR Recombinant Expressed in
Liu Y; Yin Y; Song Y; Wang K; Wu F; Jiang H
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32806654
[TBL] [Abstract][Full Text] [Related]
11. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Marks MJ; Christensen S; Dowell C; Collins AC; McIntosh JM
J Pharmacol Exp Ther; 2008 Jun; 325(3):910-9. PubMed ID: 18323456
[TBL] [Abstract][Full Text] [Related]
13. Molecular simulation study of the unbinding of α-conotoxin [ϒ4E]GID at the α7 and α4β2 neuronal nicotinic acetylcholine receptors.
Suresh A; Hung A
J Mol Graph Model; 2016 Nov; 70():109-121. PubMed ID: 27721068
[TBL] [Abstract][Full Text] [Related]
14. Alpha-conotoxin analogs with additional positive charge show increased selectivity towards Torpedo californica and some neuronal subtypes of nicotinic acetylcholine receptors.
Kasheverov IE; Zhmak MN; Vulfius CA; Gorbacheva EV; Mordvintsev DY; Utkin YN; van Elk R; Smit AB; Tsetlin VI
FEBS J; 2006 Oct; 273(19):4470-81. PubMed ID: 16956365
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
16. Alpha-conotoxins ImI and ImII target distinct regions of the human alpha7 nicotinic acetylcholine receptor and distinguish human nicotinic receptor subtypes.
Ellison M; Gao F; Wang HL; Sine SM; McIntosh JM; Olivera BM
Biochemistry; 2004 Dec; 43(51):16019-26. PubMed ID: 15609996
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of αM-conotoxin SIIID, a reversible human α7 nicotinic acetylcholine receptor antagonist.
Wang H; Li Y; Yang M; Zhou M
Toxicon; 2022 Apr; 210():141-147. PubMed ID: 35255330
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
19. Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity.
Luo S; Nguyen TA; Cartier GE; Olivera BM; Yoshikami D; McIntosh JM
Biochemistry; 1999 Nov; 38(44):14542-8. PubMed ID: 10545176
[TBL] [Abstract][Full Text] [Related]
20. MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors.
Jin AH; Vetter I; Dutertre S; Abraham N; Emidio NB; Inserra M; Murali SS; Christie MJ; Alewood PF; Lewis RJ
Biochemistry; 2014 Jan; 53(1):1-3. PubMed ID: 24351107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
